학술논문
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial
Document Type
Article
Author
Source
In: Nature Communications . (Nature Communications, December 2023, 14(1))
Subject
Language
English
ISSN
20411723